AI assistant
PFIZER INC — Director's Dealing 2020
Mar 3, 2020
29831_dirs_2020-03-03_afd51f6a-b155-4f8e-8402-5fce64b45b8f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2020-02-28
Reporting Person: SUSMAN SALLY (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-02-28 | Common Stock | M | 91408.0000 | $27.3700 | Acquired | 222496.0000 | Direct |
| 2020-02-28 | Common Stock | F | 23517.0000 | $33.4200 | Disposed | 198979.0000 | Direct |
| 2020-02-28 | Common Stock | F | 47221.0000 | $36.4500 | Disposed | 151758.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-02-28 | Stock Appreciation Rights | $27.3700 | M | 91408.0000 | Disposed | 2020-02-28 | Common Stock (91408.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 694.0000 | Indirect |
Footnotes
F1: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
F2: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
F3: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
F4: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.